Cordlife Group (SG:P8A) has released an update.
Cordlife Group Limited is ramping up its laboratory and technical staff recruitment as part of a strategic initiative for FY2024, aiming to enhance operational excellence and solidify its foundational processes in response to previous service disruptions. The company is addressing issues related to suboptimal temperature storage conditions, offering refunds to clients with affected cord blood units and committing to long-term storage and replacement solutions if viability criteria are not met. Cordlife is actively engaged with the Ministry of Health to update on corrective measures and clarifies that its international subsidiary storage tanks are not impacted.
For further insights into SG:P8A stock, check out TipRanks’ Stock Analysis page.
